Literature DB >> 30272226

Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.

Iris Navarro-Millán1,2, Parag Goyal1,3, Monika M Safford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30272226      PMCID： PMC6532442          DOI： 10.1093/rheumatology/key302

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives.

Authors:  Christie M Bartels; Tonya J Roberts; Karen E Hansen; Elizabeth A Jacobs; Andrea Gilmore; Courtney Maxcy; Barbara J Bowers
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-04       Impact factor: 4.794

2.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Authors:  Alberico L Catapano; Ian Graham; Guy De Backer; Olov Wiklund; M John Chapman; Heinz Drexel; Arno W Hoes; Catriona S Jennings; Ulf Landmesser; Terje R Pedersen; Željko Reiner; Gabriele Riccardi; Marja-Riita Taskinen; Lale Tokgozoglu; W M Monique Verschuren; Charalambos Vlachopoulos; David A Wood; Jose Luis Zamorano; Marie-Therese Cooney
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

3.  Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis.

Authors:  JaeJin An; Evo Alemao; Kristi Reynolds; Hugh Kawabata; Daniel H Solomon; Katherine P Liao; Fang Niu; T Craig Cheetham
Journal:  J Rheumatol       Date:  2016-09-01       Impact factor: 4.666

4.  Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.

Authors:  Elena Myasoedova; Cynthia S Crowson; Hilal Maradit Kremers; Veronique L Roger; Patrick D Fitz-Gibbon; Terry M Therneau; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2011-01-07       Impact factor: 19.103

5.  Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis.

Authors:  Christie M Bartels; Amy J H Kind; Christine Everett; Matthew Mell; Patrick McBride; Maureen Smith
Journal:  Arthritis Rheum       Date:  2011-05

Review 6.  Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis.

Authors:  Cheryl Barnabe; Billie-Jean Martin; William A Ghali
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

Review 7.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Authors:  R Agca; S C Heslinga; S Rollefstad; M Heslinga; I B McInnes; M J L Peters; T K Kvien; M Dougados; H Radner; F Atzeni; J Primdahl; A Södergren; S Wallberg Jonsson; J van Rompay; C Zabalan; T R Pedersen; L Jacobsson; K de Vlam; M A Gonzalez-Gay; A G Semb; G D Kitas; Y M Smulders; Z Szekanecz; N Sattar; D P M Symmons; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2016-10-03       Impact factor: 19.103

Review 8.  Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?

Authors:  Kathrin Danninger; Uta C Hoppe; Herwig Pieringer
Journal:  Int J Rheum Dis       Date:  2014-06-16       Impact factor: 2.454

9.  Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; David C Goff; Donald M Lloyd-Jones; Sidney C Smith; Conrad Blum; J Sanford Schwartz
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

Authors:  Iris Navarro-Millán; Christina Charles-Schoeman; Shuo Yang; Joan M Bathon; S Louis Bridges; Lang Chen; Stacey S Cofield; Louis J Dell'Italia; Larry W Moreland; James R O'Dell; Harold E Paulus; Jeffrey R Curtis
Journal:  Arthritis Rheum       Date:  2013-06
  10 in total
  4 in total

1.  Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply.

Authors:  Iris Navarro-Millán; Parag Goyal; Monika M Safford
Journal:  Rheumatology (Oxford)       Date:  2020-02-01       Impact factor: 7.580

Review 2.  Cardiac and vascular complications in rheumatoid arthritis.

Authors:  Prashanth Rawla
Journal:  Reumatologia       Date:  2019-02-28

Review 3.  Cardiovascular Risk Prediction Parameters for Better Management in Rheumatic Diseases.

Authors:  Abhinav Sharma; Ruxandra Christodorescu; Ahmad Agbariah; Daniel Duda-Seiman; Diala Dahdal; Dana Man; Nilima Rajpal Kundnani; Octavian Marius Cretu; Simona Dragan
Journal:  Healthcare (Basel)       Date:  2022-02-07

4.  Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients.

Authors:  Hemi Luan; Wanjian Gu; Hua Li; Zi Wang; Lu Lu; Mengying Ke; Jiawei Lu; Wenjun Chen; Zhangzhang Lan; Yanlin Xiao; Jinyue Xu; Yi Zhang; Zongwei Cai; Shijia Liu; Wenyong Zhang
Journal:  J Transl Med       Date:  2021-12-07       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.